Viewing Study NCT01662895


Ignite Creation Date: 2025-12-24 @ 2:16 PM
Ignite Modification Date: 2026-01-23 @ 2:12 PM
Study NCT ID: NCT01662895
Status: TERMINATED
Last Update Posted: 2019-06-12
First Post: 2012-07-30
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: High-Dose Deferoxamine in Intracerebral Hemorrhage
Sponsor: Beth Israel Deaconess Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2012P-000005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None NIH View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View